IFNβ-1a in vivo treatment effect on CIS multiple sclerosis patients: peripheral blood mononuclear cells - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

IFNβ-1a in vivo treatment effect on CIS multiple sclerosis patients: peripheral blood mononuclear cells

Analysis of PBMCs from patients with clinically isolated syndrome suggestive of multiple sclerosis (CIS) after 12 months of IFNβ-1a treatment. All patients exhibited a favorable response to IFN-β-1a treatment. Results provide insight into the role of endogenous IFN-β in the pathogenesis of MS.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 6 individual, 2 protocol sets

Platform:: GPL570
Series:: GSE53716
12 Samples

Download data: CEL

DataSet

Accession:: GDS4994

ID:: 4994

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity